Carlson Capital L P Amarin Corp Plcuk Transaction History

Carlson Capital L P

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2020 Aug 14, 2020	SELL	$4.78 - $8.26 $95,600 - $165,200	-20,000 Closed	0 $0
Q1 2020 May 14, 2020	BUY	$4.0 - $21.53 $12,000 - $64,590	3,000 Added 17.65%	20,000 $80,000
Q4 2019 Feb 14, 2020	SELL	$13.94 - $24.12 $1.9 Million - $3.28 Million	-136,000 Reduced 88.89%	17,000 $364,000
Q3 2019 Nov 13, 2019	SELL	$13.89 - $23.16 $1.56 Million - $2.59 Million	-112,000 Reduced 42.26%	153,000 $2.32 Million
Q2 2019 Aug 12, 2019	BUY	$16.27 - $20.51 $514,538 - $648,628	31,625 Added 13.55%	265,000 $5.14 Million
Q1 2019 May 14, 2019	BUY	$12.61 - $22.33 $2.94 Million - $5.21 Million	233,375 New	233,375 $4.85 Million

181

69.6M

258K

98K

Ticker AMRN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 403,206,016
Market Cap $210M
Description
Amarin Corporation plc, a pharmaceutical company, engages in the development and commercialization of therapeutics for the treatment of cardiovascular diseases in the United States, Germany, Canada, Lebanon, and the United Arab Emirates. Its lead product is VASCEPA, a prescription-only omega-3 fatty acid product, used as an adjunct to diet for r...

Get notified when there are updates to the investment portfolio of Carlson Capital L P, based on Form 13F filings with the SEC.

Stay updated on Carlson Capital L P with notifications on news.